Senior Global Medical Advisor - Oncology-Remote (Ridgefield, CT, United States, Connecticut)

Description

As an employee of Boehringer Ingelheim, you will actively contribute to the discovery, development, and delivery of our products to our patients and customers. Our global presence provides opportunity for all employees to collaborate internationally, offering visibility and opportunity to directly contribute to the companies' success. We realize that our strength and competitive advantage lie with our people. We support our employees in several ways to foster a healthy working environment, meaningful work, mobility, networking, and work-life balance. Our competitive compensation and benefit programs reflect Boehringer Ingelheim's high regard for our employees.

The Senior Global Medical Advisor (SR GMA) designs the global Medical affairs strategy for the compounds and leads global strategic initiatives, providing guidance to regional and local medical initiatives. The incumbent is the medical ambassador for the asset to internal and external stakeholders. The position holder takes an active role in shaping the Evidence Strategy and Generation by working closely with the Evidence Lead and the Evidence Sub-Team.

In some cases, the SR GMA may assume the responsibility of an Evidence Lead in the Asset Teams, leading the creation and execution of a holistic evidence generation strategy and integrating the deliverables of all medical functions as the leader of the Evidence team. The incumbent will drive patient value, patient voice and quality of life & outcomes in line with Medicine Excellence goals.

Duties & Responsibilities

Plans for medically adequate commercialization from early development throughout the whole asset life cycle.

Contributes to the design of brand strategic goals to allow for efficient, scientifically and medically adequate commercialization efforts starting at early development until the end of the product's life cycle.

The Medical Affairs strategy related to early pipeline compounds/indication/portfolio aims to contribute to the clinical development plans and overall evidence generation to ensure successful commercialization after launch and until the end of lifecycle.

Medical Affairs Planning & Execution:

Accountable for developing the medical narrative for the asset which informs evidence generation as well as communication strategy.

Leads the Medical Affairs strategic initiatives like publication planning the development of data roll-out e.g., and contributes, influences and has responsibilities for the execution of other functions strategies and respective tactical plans.

Leads the development of the content for medical activities and oversees the activities of the Medical Communications Content Manager who creates the content for medical communication.

Strategically plans and oversees the executing of the studies that have been defined in the Integrated Asset Evidence Plan.

Develops global medical communication strategy for the compound/indication/portfolio and oversees the execution.

Contributes and advises on the regional/local medical initiatives of the (early) Integrated Brand & tactical Plan. Where applicable acts as country/regional Brand Team Representative (BTR) and is accountable for ensuring core markets feedback is reflected in the Global Strategy.

Develops and provides guidance to countries regarding their local resourcing and planning starting 3-5 years prior to launch.

External Expert Engagement & Scientific Leadership:

Accountable for expert identification & engagement, planning and executing advisory boards & consultancy meetings in cooperation with Scientific Relations, driving patient engagement in cooperation with Patient Advocacy Relations (PAR) and their respective plans.

Represents BI and leads or takes active role at international scientific Advisory Boards, expert panels, round tables at Scientific Societies.

Competitive landscape analysis & scenario planning:

Holds an in-depth understanding of the competitor landscape from the medical perspective including possible disruptive innovations and alternative treatments and is responsible for issue preparedness including scenario planning and anticipating competitor communication strategies.

Develops competitive simulation exercises to challenge BIs own strategy vs. current and upcoming competitors.

Requirements

Advanced degree in Medical or Life Science, PhD.

Accomplished industry professional with a broad knowledge of all phases of drug development

Market-relevant experience, including external stakeholder engagement in the therapeutic area (Global, Regional or local).

Entrepreneurial mind-set and passion to build the asset for success.

For early Medical Affairs: Past exposure to all the activities involved in successfully developing and launching assets and brands.

Sound therapeutic area background with a minimum of ten (10) years in the Pharmaceutical Industry (Medical Affairs and/or Clinical Development roles, roles in combination with market knowledge and savviness, Management experience considered a plus).

For roles in Early Medical Affairs: Track record in product launch activities in the medical function.

Medical and scientific leadership to drive high-priority projects in collaboration with global matrix teams, regional/local counterparts and external partners.

Ability to establish strong partnerships at eye-level with top-level external experts, international societies and other relevant international stakeholders. Ability to influence the scientific space.

Ability to listen to customers and patients and understand their needs to bring them into the organization.

Successful track record in planning, conducting and publication of Basic Science and/or Clinical Research and in Epidemiology and Real-World Evidence and its use for various audiences.

Excellent communication & influencing skills.

Excellent presentation, training and facilitation skills.

Excellent cross-functional collaboration skills and ability to work in virtual teams and influence across matrix environment.

Ability to act with grace and resilience under pressure.

Ability to handle and lead complex projects & programs.

Full command of English Language.

Situational Responsiveness.

Deals with Ambiguity.

Strong leadership skills.

Eligibility Requirements :

Must be legally authorized to work in the United States without restriction.

Must be willing to take a drug test and post-offer physical (if required).

Must be 18 years of age or older.

Desired Skills, Experience and Abilities

Additional Duties & Responsibilities :

Patient benefit & Payor value:

Closely cooperates with the Market Access/HEOR colleagues to establish the pharmacoeconomic value of the compound, contribute to payer engagement and integrated healthcare solutions as well as developing programs to grant patients with no further therapeutic options early access.

Evidence & insights Generation:

Engages actively with Key External Experts (KEE) exchanging scientific and medical data to collect insights and inform compounds development plans and global brand strategies.

Ensures the Medical Narrative is leveraged to inform the planning and execution for Evidence Generation.

In case the Sr. Global Medical Advisor acts as Evidence Lead, a strategy to cover identified Evidence needs is defined and the optimal source of evidence defined (Randomized Clinical Trial, Real-World Evidence, Market Research and others).

Brings the needs and expectations of a broad range of customers, including patients and HCPs insights into the asset team to inform strategic direction of asset development (e.g., make sure Target Product Profile is validated with external experts and reflects patient’s needs and inform Clinical Trial Protocols). This includes services and solutions beyond the product supporting patients and caregivers in managing the disease.

Leads the development of strategies to further establish the clinical benefits and risks beyond initial clinical development in line with the Medical narrative and PMO and in close collaboration with the members of the Evidence Team and Clinical Operations where appropriate. This can include coordination and guidance for investigator initiated studied (IIS), external collaboration research (ECR), design of phase IV trials Compassionate-use/Early-access Programs. The development and roll-out of non-interventional (NIS) and real-world studies happens in close alignment with Global Medical Affairs.

If part of the Asset Evidence sub-team or acting as the Evidence Lead, oversees Clinical Development strategy for the respective asset.

Cross-functional cooperation:

Closely collaborates with all relevant internal global functions (e.g., Marketing, PPSS (Product Pipeline Scientific Support), PAR, Corporate Communications, Legal, Epidemiology & RWE, early and late-stage Clinical Development teams, Regulatory Affairs, Drug Safety, Digital).